What is the Buying Price of Alembic Pharmaceuticals Share?

The Buying Price of Alembic Pharmaceuticals share is 784.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

How to buy Alembic Pharmaceuticals Share at Choice?

To buy Alembic Pharmaceuticals stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alembic Pharmaceuticals, choose your preferred order type, and place the trade.

What is the PE ratio of Alembic Pharmaceuticals Shares?

The Price-to-earnings (P/E) ratio of Alembic Pharmaceuticals shares is 22.86. You can compare it with the sector average for relative valuation.

What is the PB ratio of Alembic Pharmaceuticals Shares?

The Price to Book (P/B) ratio Alembic Pharmaceuticals shares is 2.72. Useful to assess the stock's value relative to its book value.

Is Alembic Pharmaceuticals Overvalued?

To assess Alembic Pharmaceuticals’s valuation compare Sector P/E, P/B which are 71.32 & 3.45 with sector averages, along with growth rates and financial metrics.

What is the Market Cap of Alembic Pharmaceuticals?

The Market Cap of Alembic Pharmaceuticals is 15412.51 CR. It indicates the company's size category and trading liquidity.

What is the 52 Week High and Low of Alembic Pharmaceuticals Share Price?

The 52 week high and low prices of Alembic Pharmaceuticals share price is 1107.9 & 635.8. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Which sector does Alembic Pharmaceuticals belong to?

Alembic Pharmaceuticals belongs to the Healthcare sector.

Alembic Pharmaceuticals Share price

APLLTD

Healthcare Large Cap

784.1

1.60 (-0.20%)

NSE

BSE

Last updated on 15 May, 2026 | 15:45 IST

BUYSELL

Today's High

809.00

Today's Low

769.50

52 Week Low

635.80

52 Week High

1107.90

Free Demat with Zero AMC*

Alembic Pharmaceuticals Chart

ChartIQ

TradingView

Alembic Pharmaceuticals Share Key Metrics

Volume

3.76 L

Market Cap

15412.51 CR

LTQ@LTP

10@784.10

ATP

785.7 Var Margin

16.14 %

Circuit Range

628.6-942.8

Delivery %

22.31 %

Value

29.55 CR

ASM/GSM

No

Market Lot

1

Summary

15 May, 2026 | 15:45 को, Alembic Pharmaceuticals का शेयर प्राइस आज ₹784.1 पर है, जो दिन के लिए 1.60% की -0.20 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹769.50 और ₹809.00 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹635.80 से ₹1107.90 तक रही है। ट्रेडिंग गतिविधि के मामले में, Alembic Pharmaceuticals ने 376042 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹196563124 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹78570 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 10,78410 रही। यह स्टॉक ₹628.6-942.8 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹29.55 CR है। दिन के लिए डिलीवरी परसेंटेज 22.31% रही। इसके अतिरिक्त, Alembic Pharmaceuticals वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Alembic Pharmaceuticals Fundamentals

P/E Ratio

22.86

P/B Ratio

2.72

Div. Yield

1.53

Sector P/E

71.32

Sector P/B

3.45

Sec. Div. Yield

0.56

Alembic Pharmaceuticals Resistance and Support

Pivot 782.1

Resistance

First Resistance

794.2

Second Resistance

802.7

Third Resistance

814.8

Support

First Support

773.6

Second Support

761.5

Third Support

753

Alembic Pharmaceuticals Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

69.74%

Mutual Fund

8.18%

Insurance

7.68%

Foreign Institutional Investors

4.26%

Domestic Institutional Investors

0.31%

Retail

9.83%

Others

0%

Total Promoters

MAR '26

69.74%

Alembic Pharmaceuticals Corporate Actions

Date	Agenda
2026-05-15	Audited Results & Final Dividend
2026-02-05	Quarterly Results

Alembic Pharmaceuticals News

Alembic Pharmaceuticals Ltd - 533573 - Alembic Pharmaceuticals Limited Passes ANVISA (Brazil) GMP Inspection For Its API-III Facility At Karakhadi.

Alembic Pharma successfully completed the ANVISA (Brazil) GMP inspection for its API-III Facility at Karakhadi. This indicates compliance with Good Manufacturing Practices, crucial for continued operations and market access in Brazil.

May 15 2026 20:05:00

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Alembic Pharma announced Q4 FY26 results with revenue up 4% YoY to Rs.1,848 crore and net profit up 29% YoY to Rs.203 crore. The company also launched its US Branded Business, Pivya, during the quarter.

May 15 2026 14:05:00

Alembic Pharmaceuticals Ltd - 533573 - Board Meeting Outcome for Outcome Of Board Meeting

Alembic Pharmaceuticals' board approved Q4 FY26 cons. revenue of ₹1,876.31 cr and net profit of ₹202.70 cr. The company also recommended a final dividend of ₹12 per equity share for FY26. This reflects a positive operational and financial performance for the quarter and fiscal year.

May 15 2026 14:05:00

Alembic Pharmaceuticals Ltd - 533573 - Alembic Pharmaceuticals Limited Receives Establishment Inspection Report (EIR) For Its Injectable Facility (F-III) Located At Karakhadi.

Alembic Pharmaceuticals received the Establishment Inspection Report (EIR) from the USFDA for its Injectable facility (F-III) located at Karakhadi on May 13, 2026. This indicates the conclusion of the inspection conducted from February 9-18, 2026.

May 14 2026 11:05:00

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Alembic Pharma received USFDA tentative approval for Darolutamide Tablets, 300 mg. This approval targets a significant market size estimated at US$3,155 million by March 2026.

May 14 2026 10:05:00

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Change in Management

Alembic Pharmaceuticals designated Mr. Amit Nayak as Senior Management Personnel effective May 1, 2026. He brings 12 years of experience in commercial excellence from pharma and consulting firms.

May 01 2026 10:05:00

Alembic Pharmaceuticals Ltd - 533573 - Intimation Under Regulation 30 Of SEBI LODR Regulations, 2015 - Incorporation Of Subsidiary Company

Alembic Pharmaceuticals Limited incorporated Alembic Lifesciences Philippines Inc. in the Philippines. This new subsidiary, with a share capital of Philippine Pesos 12 million, will focus on promoting and distributing pharmaceutical products in the region.

Apr 22 2026 19:04:00

NSE : 25328

BSE : 533573

ISIN : INE901L01018

Alembic Pharmaceuticals Management

Name	Position
Chirayu Amin	Chairman & CEO
Pranav Amin	Managing Director

Alembic Pharmaceuticals Similar Stocks

Eris Lifesciences Ltd.

1370.90

-3.00 (0.22%)

Granules India Ltd.

736.20

0.90 (0.12%)

Cohance Lifesciences Ltd.

423.20

-22.00 (4.94%)

Poly Medicure Ltd.

1498.90

-22.10 (1.45%)

Jubilant Pharmova Ltd.

990.15

-14.25 (1.42%)

Dr. Agarwal's Health Care Ltd.

450.10

3.85 (0.86%)

Caplin Point Laboratories Ltd.

1998.80

-25.00 (1.24%)

Vijaya Diagnostic Centre Ltd.

1329.20

59.30 (4.67%)

Rainbow Children's Medicare Ltd.

1336.20

20.00 (1.52%)

Alivus Life Sciences Ltd.

1044.60

-19.50 (1.83%)

Alembic Pharmaceuticals FAQs

Alembic Pharmaceuticals शेयर का खरीद मूल्य 784.1 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Alembic Pharmaceuticals शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Alembic Pharmaceuticals शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 22.86 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Alembic Pharmaceuticals शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 2.72 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Alembic Pharmaceuticals शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.45 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Alembic Pharmaceuticals का मार्केट कैप 15412.51 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Alembic Pharmaceuticals शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 1107.90 और 635.80 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।